Page last updated: 2024-10-22

aprindine and Hypertension

aprindine has been researched along with Hypertension in 1 studies

Aprindine: A class Ib anti-arrhythmia agent used to manage ventricular and supraventricular arrhythmias.

Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.

Research Excerpts

ExcerptRelevanceReference
"A multicenter, placebo-controlled, randomized, double-blind trial compared the preventive effect of aprindine and digoxin on the recurrence of atrial fibrillation (AF) with placebo, and also compare the effectiveness of these 2 drugs in the prevention of AF."9.10Double-blind placebo-controlled trial of aprindine and digoxin for the prevention of symptomatic atrial fibrillation. ( Atarashi, H; Fukunami, M; Hamada, C; Inoue, H; Origasa, H; Sugi, K, 2002)
"A multicenter, placebo-controlled, randomized, double-blind trial compared the preventive effect of aprindine and digoxin on the recurrence of atrial fibrillation (AF) with placebo, and also compare the effectiveness of these 2 drugs in the prevention of AF."5.10Double-blind placebo-controlled trial of aprindine and digoxin for the prevention of symptomatic atrial fibrillation. ( Atarashi, H; Fukunami, M; Hamada, C; Inoue, H; Origasa, H; Sugi, K, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atarashi, H1
Inoue, H1
Fukunami, M1
Sugi, K1
Hamada, C1
Origasa, H1

Trials

1 trial available for aprindine and Hypertension

ArticleYear
Double-blind placebo-controlled trial of aprindine and digoxin for the prevention of symptomatic atrial fibrillation.
    Circulation journal : official journal of the Japanese Circulation Society, 2002, Volume: 66, Issue:6

    Topics: Aged; Anti-Arrhythmia Agents; Aprindine; Atrial Fibrillation; Coronary Disease; Diabetic Angiopathie

2002